Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arun Satelli

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Scientific Reports|July 2, 2016
Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patientsArun Satelli, Izhar Singh Batth, Zachary Brownlee, et al.
Hepatology (Baltimore, Md.)|October 30, 2014
IL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in miceAbhisek Mitra, Arun Satelli, Jun Yan, et al.
Oncology Reports|February 22, 2008
Varied expression and localization of multiple galectins in different cancer cell linesArun Satelli, Prema S Rao, Prem K Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2014
Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progressionArun Satelli, Abhisek Mitra, Zachary Brownlee, et al.
Oncotarget|May 19, 2017
EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progressionArun Satelli, Izhar Batth, Zachary Brownlee, et al.
International Journal of Cancer|June 8, 2020
Cell surface vimentin-positive circulating tumor cell-based relapse prediction in a long-term longitudinal study of postremission neuroblastoma patientsIzhar S Batth, Long Dao, Arun Satelli, et al.
Cancer Research|January 23, 2014
Universal marker and detection tool for human sarcoma circulating tumor cellsArun Satelli, Abhisek Mitra, Jeffry J Cutrera, et al.
Frontiers in Oncology|December 27, 2021
Prognostic Value of Cell-Surface Vimentin-Positive CTCs in Pediatric SarcomasLong Dao, Dristhi Ragoonanan, Izhar Batth, et al.
Proteomics|March 6, 2018
Translating Immunopeptidomics to Immunotherapy-Decision-Making for Patient and Personalized Target SelectionJens Fritsche, Barbara Rakitsch, Franziska Hoffgaard, et al.
Journal for Immunotherapy of Cancer|July 22, 2024
First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumorsMartin Wermke, Tobias A W Holderried, Jason John Luke, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Scientific Reports|July 2, 2016
Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patientsArun Satelli, Izhar Singh Batth, Zachary Brownlee, et al.
Hepatology (Baltimore, Md.)|October 30, 2014
IL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in miceAbhisek Mitra, Arun Satelli, Jun Yan, et al.
Oncology Reports|February 22, 2008
Varied expression and localization of multiple galectins in different cancer cell linesArun Satelli, Prema S Rao, Prem K Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2014
Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progressionArun Satelli, Abhisek Mitra, Zachary Brownlee, et al.
Oncotarget|May 19, 2017
EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progressionArun Satelli, Izhar Batth, Zachary Brownlee, et al.
International Journal of Cancer|June 8, 2020
Cell surface vimentin-positive circulating tumor cell-based relapse prediction in a long-term longitudinal study of postremission neuroblastoma patientsIzhar S Batth, Long Dao, Arun Satelli, et al.
Cancer Research|January 23, 2014
Universal marker and detection tool for human sarcoma circulating tumor cellsArun Satelli, Abhisek Mitra, Jeffry J Cutrera, et al.
Frontiers in Oncology|December 27, 2021
Prognostic Value of Cell-Surface Vimentin-Positive CTCs in Pediatric SarcomasLong Dao, Dristhi Ragoonanan, Izhar Batth, et al.
Proteomics|March 6, 2018
Translating Immunopeptidomics to Immunotherapy-Decision-Making for Patient and Personalized Target SelectionJens Fritsche, Barbara Rakitsch, Franziska Hoffgaard, et al.
Journal for Immunotherapy of Cancer|July 22, 2024
First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumorsMartin Wermke, Tobias A W Holderried, Jason John Luke, et al.
Pageof 3